Skip to main content
MethodsX logoLink to MethodsX
. 2021 Mar 10;8:101304. doi: 10.1016/j.mex.2021.101304

A method to establish a chronic restraint stress mouse model with colorectal cancer xenografts

Shiyun Shao a,b, Zhaozhou Zhang a,b, Yingru Zhang a,b, Ru Jia a, Yiyang Zhao a, Qi Li a,b,, Yan Wang a,
PMCID: PMC8374275  PMID: 34434824

Abstract

Colorectal cancer (CRC) remains one of the most common clinical cancers of digestive tract. Recently, a large number of researches have shown that chronic stress can actively participate in the development of CRC. The proposed method successfully established the model of chronic stress mouse model with colorectal cancer.

  • Chronic restraint stress (CRS) was used to establish chronic stress model.

  • CRS was combined with a colorectal cancer xenografts model.

  • Behavioural tests and tumour growth were used to evaluate model construction.

Keywords: Chronic stress, Depression, Colorectal cancer

Graphical abstract

Image, graphical abstract


Specifications table

Subject Area: Biochemistry, Genetics and Molecular Biology
More specific subject area: Developing a chronic stress mouse model with colorectal cancer
Method name: Chronic restraint stress mouse model with colorectal cancer xenografts
Name and reference of original method: Z. Feng, L. Liu, C. Zhang, T. Zheng, J. Wang, M. Lin, Y. Zhao, X. Wang, A.J. Levine, W. Hu, Chronic restraint stress attenuates p53 function and promotes tumorigenesis, Proc Natl Acad Sci U S A 109(18) (2012) 7013-8.
Resource availability: Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

Background

Colorectal cancer (CRC) is one of the most common clinical malignant cancers worldwide that is responsible for approximately 25% of cancer-related deaths every year [1], [2]. Depression is a common psychological complication of CRC, and the presence of chronic stress has a major impact on depression [3], [4]. Patients with CRC experience long and painful diagnosis and treatment processes, and continuous psychological stress often places these patients in a state of chronic stress [5], [6]. Many clinical and epidemiological studies have confirmed that chronic stress increases the risk for CRC progression [7], [8].

The method described in this research arms to further investigate the mechanisms of chronic stress and CRC.

Method details

Cell culture

Human colon cancer cell lines (HCT116 and LoVo) were acquired from the Cell Bank of the Institute of Cancer Research, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine. HCT116 cells were cultured and passaged conventionally at 37 °C in an atmosphere of 5% CO2 and 95% air in RPMI-1640 (Gibco, USA) containing 10% foetal bovine serum (FBS).

Mice and animal care

Male athymic nude mice (NCr-nu), which were 6-7 weeks old and weighed 20–22 g, were purchased from Shanghai Sino-British SIPPR/BK. Mice were housed in a sterile laminar flow environment at the specific-pathogen-free (SPF) Experimental Animal Centre of Traditional Chinese Medicine at Shanghai University under a 12 h/12 h light/dark cycle at a temperature of 22 ± 2 °C and a relative humidity of 60 ± 5%, with access to a fresh food and water ad libitum. All experiments were in accordance with U.S. National Institutes of Health protocols in the Guide for the Care and Use of Laboratory Animals (8th edition).

Chronic restraint stress (CRS) model

Mice were bound to well-ventilated restraint 50 mL tubes without food and water from 8:00 AM to 16:00 PM for 14 consecutive days. The mice could not move freely or turn around but were not oversqueezed; this procedure induces chronic stress but not pain or injury. Mice in the control group were left in their usual environment and were undisturbed for 14 days (Fig. 1).

Fig. 1.

Fig 1

Schematic showing the timing of CRS and tumour injection.

Behavioral test

Sucrose preference test (SPT)

Before this test, all animals were simultaneously given two water bottles for 3 consecutive days, one containing water (200 mL) and the other containing a 1% sucrose solution (200 mL, Sigma-Aldrich). The placement of the 2 water bottles was reversed each day. Mice were deprived of water for 15 h before the test, which began at 8 AM. Each mouse was exposed to two identical weighed bottles (1% sucrose solution or water), and the bottles were then weighed after 8 h. Sucrose preference was calculated as the percentage of consumed sucrose solution relative to total liquid intake.

Tail suspension test (TST)

Mice were suspended 60 cm above the floor by adhesive tape placed approximately 1 cm from the tip of the tail. The duration of immobility was recorded for 6 min by an investigator blinded to group allocations. The immobility time was recorded during the last 4 min after 2 min of habituation. Mice were considered immobile only when they hung passively and were completely motionless. Any mice that climbed their tails were not considered in the experimental analysis.

CRC xenograft animal model

Mice were injected subcutaneously the resuspended HCT116 cells (2 × 106 cells in 100 µl). After subcutaneous xenograft, the tumour volume was measured using a vernier calliper every 3 days.

Statistical analysis

The survival analyses were carried out using GraphPad Prism (version 8.0), and Kaplan–Meier curves was used for the survival analyses.

Depressive behavior in the CRS mouse model with CRC xenografts

We confirmed the establishment of this mouse model by behavioural testing (Fig. 2). Compared with the control group(only injected tumour cells), the sucrose preference of the model group was lower (P < 0.01) and the tail suspension time was longer(P < 0.01).

Fig. 2.

Fig 2

Behavioral tests of CRS model. (A)The sucrose preference of the SPT in each group(n = 5). (B)The immobility time of the TST in each group (n = 5). ⁎⁎P < 0.01 compared with the control group.

Tumour growth and survival time of CRS model with CRC xenografts

Our results indicated that tumour volume was greater in the model group than in the control group. Moreover, analysis of overall survival (OS) indicated that the model group had the shorter OS (Fig. 3).

Fig. 3.

Fig 3

Tumour growth and survival time of CRS model with CRC xenografts. (A) (a) Tumour growth curves (n = 10). (b) Overall survival curve. Survival rates were presented as Kaplan-Meier survival curves (n = 10). ⁎⁎P < 0.01 compared with the control group.

Declaration of Competing Interest

The authors have declared no conflict of interest.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 82030120 and 82074232) and the Project of Shanghai Science and Technology Committee (19401972200).

Contributor Information

Qi Li, Email: qili@shutcm.edu.cn.

Yan Wang, Email: yanwang@shutcm.edu.cn.

References

  • 1.Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. [DOI] [PubMed] [Google Scholar]
  • 2.Dekker E., Tanis P.J., Vleugels J.L.A., Kasi P.M., Wallace M.B. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi: 10.1016/S0140-6736(19)32319-0. [DOI] [PubMed] [Google Scholar]
  • 3.Hammen C. Stress and depression. Ann. Rev. Clin. Psychol. 2005;1(1):293–319. doi: 10.1146/annurev.clinpsy.1.102803.143938. [DOI] [PubMed] [Google Scholar]
  • 4.Mols F., Schoormans D., de Hingh I., Oerlemans S., Husson O. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES registry: prevalence, predictors, and impact on quality of life. Cancer. 2018;124(12):2621–2628. doi: 10.1002/cncr.31369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kikuchi N., Nishiyama T., Sawada T., Wang C., Lin Y., Watanabe Y., Tamakoshi A., Kikuchi S. Perceived stress and colorectal cancer incidence: the Japan collaborative cohort study. Sci. Rep. 2017;7:40363. doi: 10.1038/srep40363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang Z., Shao S., Zhang Y., Jia R., Hu X., Liu H., Sun M., Zhang B., Li Q., Wang Y. Xiaoyaosan slows cancer progression and ameliorates gut dysbiosis in mice with chronic restraint stress and colorectal cancer xenografts. Biomed. Pharmacother. 2020;132:110916. doi: 10.1016/j.biopha.2020.110916. [DOI] [PubMed] [Google Scholar]
  • 7.Baritaki S., de Bree E., Chatzaki E., Pothoulakis C. Chronic stress, inflammation, and colon cancer: a CRH system-driven molecular crosstalk. J. Clin. Med. 2019;8(10) doi: 10.3390/jcm8101669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Liu J., Deng G.H., Zhang J., Wang Y., Xia X.Y., Luo X.M., Deng Y.T., He S.S., Mao Y.Y., Peng X.C., Wei Y.Q., Jiang Y. The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models. Psychoneuroendocrinology. 2015;52:130–142. doi: 10.1016/j.psyneuen.2014.11.008. [DOI] [PubMed] [Google Scholar]

Articles from MethodsX are provided here courtesy of Elsevier

RESOURCES